UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN-LABEL EXTENSION OF THE SCARLET ROAD STUDY IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE AFTER APPROXIMATELY 2 YEARS OF STUDY DURATION

Category Primary study
JournalAlzheimer's and Dementia
Year 2018
This article has no abstract
Epistemonikos ID: e71bfb998e3c19c0c9518eca0aa49cdd6365a6ee
First added on: Feb 09, 2025